about
Gram-positive and gram-negative bacterial toxins in sepsis: a brief reviewA Review of GM-CSF Therapy in SepsisCD1d- and MR1-Restricted T Cells in SepsisAsymptomatic omental granuloma following spillage of gallstones during laparoscopic cholecystectomy protects patients and influences surgeons' decisions: a reviewImmunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridgeHost innate immune responses to sepsisGlyburide reduces bacterial dissemination in a mouse model of melioidosisUnderstanding the regulation of Group B Streptococcal virulence factorsMeeting the challenge of influenza pandemic preparedness in developing countriesConfronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases.MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomalleiLipopolysaccharide (LPS) potentiates hydrogen peroxide toxicity in T98G astrocytoma cells by suppression of anti-oxidative and growth factor gene expression.Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice.Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis.Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study.Soluble ST2 plasma concentrations predict mortality in severe sepsis.Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences.The impact of Staphylococcus aureus-associated molecular patterns on staphylococcal superantigen-induced toxic shock syndrome and pneumonia.The host response to sepsis and developmental impactTranslocated LPS might cause endotoxin tolerance in circulating monocytes of cystic fibrosis patients.Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune responseNew approaches to sepsis: molecular diagnostics and biomarkers.Deletion of arcD in Streptococcus pneumoniae D39 impairs its capsule and attenuates virulenceTherapeutic interventions in sepsis: current and anticipated pharmacological agentsHost-pathogen interaction in invasive Salmonellosis.C10X polymorphism in the CARD8 gene is associated with bacteraemia.Large-scale inference of protein tissue origin in gram-positive sepsis plasma using quantitative targeted proteomics.CD39 improves survival in microbial sepsis by attenuating systemic inflammationARF6 inhibition stabilizes the vasculature and enhances survival during endotoxic shock.Streptococcus pneumoniae invades erythrocytes and utilizes them to evade human innate immunity.Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome.The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis.Mesenchymal stem cells as a therapeutic tool to treat sepsis.Increased plasma vaspin concentration in patients with sepsis: an exploratory examinationSepsis: Something old, something new, and a systems view.Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in high-mortality murine sepsisDynamic expression of leukocyte innate immune genes in whole blood from horses with lipopolysaccharide-induced acute systemic inflammation.Sepsis in the pediatric cardiac intensive care unit.
P2860
Q22305427-0BB8F585-97D1-43E5-A5EC-8A8EB7114B1FQ26774775-76B28206-9D9D-4F5E-B50C-DDD6DDD4C555Q26796132-26AC8814-6BBB-4893-880A-B3E08ED4BAB6Q26824480-152438D0-FE13-490A-9113-25B3AB4DCA09Q26830445-AD1A7160-5372-4503-A293-D29055185B6FQ26864635-708C6F69-6C8D-49D0-A7E0-C132D15968B1Q27305020-E312E510-ED84-42B3-884D-64C5F960CC5EQ28237019-2AD74B5F-18A6-4F6F-9683-2606BF748DC0Q30228213-4AA05287-5B94-437A-8668-2D908F022EA4Q30379206-C35A632E-3BE5-4940-B003-9F6153DF8C83Q30943588-512E392C-297D-4AF1-AAA1-7C552966D415Q33378896-05705549-71C1-450F-B723-77329300D4E8Q33393475-D3EE92EC-8711-4C96-B195-572320D8F4EFQ33418094-0B2C5FA1-1271-4850-91C1-C67C3D86447DQ33458347-84091D9D-CBE5-403A-895B-40342573CD74Q33532590-178319D3-4736-43FE-83C1-8CF24886573FQ33639738-33B3402D-D2EB-4464-8E16-AF535BB15FAAQ33722112-2A3B450C-3EB5-48E5-B973-1322AA49360EQ33762394-72259914-F7B6-4081-A430-046DFFF32E1CQ33850007-A4A5999E-CA59-4F37-A4D9-5711E497947DQ33950741-7F8139C1-894D-4B9E-B979-70C05E0A4518Q34117738-9E3DBC83-C9FB-4D81-BCC8-287F591725CCQ34281893-27311821-BDD3-403E-BA89-1DF533C60B3EQ34303687-038C595C-4272-4E46-88E7-DDB6B172A0FBQ34362097-70D94821-C1D3-4CEF-9F59-5997D76599E2Q34427050-A346B441-6B66-4FA2-B4EC-8E80CC8594E8Q34440638-B51E9BFA-34E2-496A-B014-3FDCDACF5CFDQ34454685-9183C60C-A3DC-468A-A575-E2A3C7EA92D6Q34507442-8F72FA47-5E79-4788-B777-956AC190BE2FQ34847971-3DF165EA-6CE9-492A-A998-A11913D14EF4Q34917691-E6A85F70-C155-4DF4-A5AE-BA27816BB627Q35032403-3C69A04A-83E5-4B2E-9A30-57627A32D8C5Q35043680-AC616D0A-FAAF-4D9C-AED9-0B60F0CBA689Q35067228-79830C7E-350D-498F-ABB3-1F78F9EE9DA8Q35205670-9E1C03C6-CE35-4C2D-9331-67492FE9AE4EQ35460094-5BE3266D-7620-493C-BA7D-8176413BA0CBQ35500956-B4E06EA3-FC87-4FEE-9DED-A189B076A114Q35555569-C2E3C2D8-9714-43A4-A0D5-3736ACF08686Q35664411-9A418850-ADDD-496A-AE69-A84C2FAC3D92Q35751940-EF02DECA-D06D-4C4E-AC77-C7B830A6D691
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Host-pathogen interactions in sepsis.
@en
Host-pathogen interactions in sepsis.
@nl
type
label
Host-pathogen interactions in sepsis.
@en
Host-pathogen interactions in sepsis.
@nl
prefLabel
Host-pathogen interactions in sepsis.
@en
Host-pathogen interactions in sepsis.
@nl
P1476
Host-pathogen interactions in sepsis.
@en
P2093
Steven M Opal
P356
10.1016/S1473-3099(07)70265-7
P577
2007-12-11T00:00:00Z